Factors Associated With Infarct-Related Artery Patency Before Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the FAST-MI 2010 Registry)
Clotilde Bailleul(Université Paris Cité), Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Patrick Goldstein(Centre Hospitalier Universitaire de Lille), Jean Ferrières(Université Fédérale de Toulouse Midi-Pyrénées), Grégory Ducrocq, François Schiele(Hôpital Saint-Jacques), Gilles Montalescot(Maastricht University Medical Centre), Meyer Elbaz(Cairo University), Yves Cottin(CHU Dijon Bourgogne), Camille Brasselet, Hervé Breton(Centre Hospitalier Universitaire de Rennes), Tabassome Simon(Sorbonne Université), Pierre Coste, Nadia Aïssaoui(Université Paris Cité), Didier Blanchard(Groupe d'Oncologie Radiothérapie Tête et Cou), Philippe Gabríel Steg(Mount Sinai Hospital), Eric Bonnefoy‐Cudraz(Hospices Civils de Lyon), Étienne Puymirat(Inserm)
Cited by 18
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k